The importance of clinical trial data sharing: toward more open science.
暂无分享,去创建一个
[1] P. Sandercock,et al. The International Stroke Trial database , 2011, Trials.
[2] P. Greenland,et al. Critical lessons from the ENHANCE trial. , 2008, JAMA.
[3] K. Dickersin,et al. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. , 1992, JAMA.
[4] D. Altman,et al. Towards agreement on best practice for publishing raw clinical trial data , 2009, Trials.
[6] A. Zwinderman,et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.
[7] D. Altman,et al. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers , 2010, BMJ : British Medical Journal.
[8] David Madigan,et al. Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. , 2009, Archives of internal medicine.
[9] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[10] Peter Doshi,et al. Neuraminidase inhibitors—the story behind the Cochrane review , 2009, BMJ : British Medical Journal.
[11] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[12] S. Nissen,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[13] Harlan M. Krumholz,et al. Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis , 2009, PLoS medicine.
[14] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[15] R. Rosenthal,et al. Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.
[16] Ian F Tannock,et al. Factors associated with failure to publish large randomized trials presented at an oncology meeting. , 2003, JAMA.
[17] J. Kirwan,et al. Making original data from clinical studies available for alternative analysis. , 1997, The Journal of rheumatology.
[18] Harlan M Krumholz,et al. A model for dissemination and independent analysis of industry data. , 2011, JAMA.
[19] E. Decullier,et al. Fate of biomedical research protocols and publication bias in France: retrospective cohort study , 2005, BMJ : British Medical Journal.
[20] D. Kleppner. Ensuring the integrity, accessibility, and stewardship of research data in the digital age , 2010 .
[21] E. Berger,et al. Ensuring the integrity, accessibility, and stewardship of research data in the digital age , 2009 .
[22] J. Ioannidis,et al. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.
[23] A. Vickers. Whose data set is it anyway? Sharing raw data from randomized trials , 2006, Trials.
[24] Peter C Gøtzsche,et al. Strengthening and opening up health research by sharing our raw data. , 2012, Circulation. Cardiovascular quality and outcomes.
[25] Mark Walport,et al. Sharing research data to improve public health , 2011, The Lancet.
[26] Harlan M Krumholz,et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.
[27] Caroline Leigh Watkins. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997 .